174 related articles for article (PubMed ID: 37405500)
41. Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.
Schurink NW; van Kranen SR; Berbee M; van Elmpt W; Bakers FCH; Roberti S; van Griethuysen JJM; Min LA; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2021 Sep; 31(9):7031-7038. PubMed ID: 33569624
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of
Kitajima K; Yamano T; Miyoshi Y; Katsuura T; Enoki T; Yamakado K
Hell J Nucl Med; 2019; 22(1):25-35. PubMed ID: 30843007
[TBL] [Abstract][Full Text] [Related]
43. 18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?
Min M; Lin P; Lee M; Shon IH; Lin M; Forstner D; Tieu MT; Chicco A; Bray V; Fowler A
J Med Imaging Radiat Oncol; 2016 Jun; 60(3):433-40. PubMed ID: 26868588
[TBL] [Abstract][Full Text] [Related]
44. Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and
Tsuchiya H; Matoba M; Nishino Y; Ota K; Doai M; Nagata H; Tuji H
Radiat Oncol; 2023 Feb; 18(1):24. PubMed ID: 36747228
[TBL] [Abstract][Full Text] [Related]
45. Correlation of [
Pisani C; Vigna L; Mastroleo F; Loi G; Amisano V; Masini L; Deantonio L; Aluffi Valletti P; Sacchetti G; Krengli M
Radiat Oncol; 2021 Mar; 16(1):57. PubMed ID: 33743759
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
Hoshikawa H; Mori T; Yamamoto Y; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
Clin Nucl Med; 2015 Jun; 40(6):464-8. PubMed ID: 25546204
[TBL] [Abstract][Full Text] [Related]
47. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
[TBL] [Abstract][Full Text] [Related]
48. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
Michielsen K; Vergote I; Op de Beeck K; Amant F; Leunen K; Moerman P; Deroose C; Souverijns G; Dymarkowski S; De Keyzer F; Vandecaveye V
Eur Radiol; 2014 Apr; 24(4):889-901. PubMed ID: 24322510
[TBL] [Abstract][Full Text] [Related]
49. Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
Noij DP; Jagesar VA; de Graaf P; de Jong MC; Hoekstra OS; de Bree R; Castelijns JA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):296-305.e2. PubMed ID: 28539202
[TBL] [Abstract][Full Text] [Related]
50.
Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
Creff G; Devillers A; Depeursinge A; Palard-Novello X; Acosta O; Jegoux F; Castelli J
JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):471-479. PubMed ID: 32215611
[TBL] [Abstract][Full Text] [Related]
52. 18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.
Ito K; Yokoyama J; Kubota K; Morooka M; Shiibashi M; Matsuda H
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1318-27. PubMed ID: 20306040
[TBL] [Abstract][Full Text] [Related]
53. Prognostic values of mid-radiotherapy
Kim N; Cho H; Yun M; Park KR; Lee CG
Radiat Oncol; 2019 Feb; 14(1):27. PubMed ID: 30717809
[TBL] [Abstract][Full Text] [Related]
54. Correlation between 18F-FDG PET/CT and diffusion-weighted MRI parameters in head and neck squamous cell carcinoma at baseline and after chemo-radiotherapy. A retrospective single institutional study.
Garau LM; Manca G; Bola S; Aringhieri G; Faggioni L; Volterrani D
Oral Radiol; 2022 Apr; 38(2):199-209. PubMed ID: 34133000
[TBL] [Abstract][Full Text] [Related]
55. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
56. The correlation of
Qu YH; Long N; Ran C; Sun J
Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
[TBL] [Abstract][Full Text] [Related]
57. Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
Wong KH; Panek R; Dunlop A; Mcquaid D; Riddell A; Welsh LC; Murray I; Koh DM; Leach MO; Bhide SA; Nutting CM; Oyen WJ; Harrington KJ; Newbold KL
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):759-767. PubMed ID: 29164301
[TBL] [Abstract][Full Text] [Related]
58. The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
Ohashi T; Terasawa K; Aoki M; Akazawa T; Shibata H; Kuze B; Asano T; Kato H; Miyazaki T; Matsuo M; Inoue N; Ito Y
Auris Nasus Larynx; 2020 Aug; 47(4):658-667. PubMed ID: 32089351
[TBL] [Abstract][Full Text] [Related]
59. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
[TBL] [Abstract][Full Text] [Related]
60. Application of Simultaneous
Huang Z; Li X; Wang Z; Meng N; Fu F; Han H; Li D; Bai Y; Wei W; Fang T; Feng P; Yuan J; Yang Y; Wang M
J Magn Reson Imaging; 2022 Jul; 56(1):63-74. PubMed ID: 34888990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
